(VIANEWS) – The Market ended the session with PCI BIOTECH HOLD (PCIB.OL) jumping 19.54% to kr2.36 on Tuesday while Oslo Børs Benchmark Index_GI fell 1.89% to kr1,415.10.
PCI BIOTECH HOLD’s last close was kr1.97, 43.71% under its 52-week high of kr3.50.
About PCI BIOTECH HOLD
PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company's technology platform consists of a proprietary small molecule photosensitiser (fimaporfin) and a light source; and develops photochemical internalisation (PCI), inducing light-triggered intracellular release for various therapeutic modalities, as well as photochemical lysis (PCL) comprising light-triggered cell lysis, which enhances yield and purity in viral vector manufacturing. It also explores for intratumoural immunotherapy therapeutics that identifies novel treatment combinations to overcome resistance to immune-checkpoint inhibitors and safety-issues associated with treatments; and develops nucleic acid therapeutics to improve the treatment of dermatological diseases. In addition, the company develops fimaVACC for immunotherapy indications, which is in pre-clinical study; fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study for bioprocessing and dermatology indications; and technology for viral vector manufacturing and pre-clinical research for intratumoural immunotherapy. PCI Biotech Holding ASA was incorporated in 2007 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, PCI BIOTECH HOLD has a trailing twelve months EPS of kr-0.54.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -42.13%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 8.4%, now sitting on 2.99M for the twelve trailing months.
Moving Average
PCI BIOTECH HOLD’s worth is way higher than its 50-day moving average of kr1.72 and way higher than its 200-day moving average of kr1.90.
Volume
Today’s last reported volume for PCI BIOTECH HOLD is 2857600 which is 606.27% above its average volume of 404601.
Volatility
PCI BIOTECH HOLD’s last week, last month’s, and last quarter’s current intraday variation average was a negative 10.54%, a positive 1.93%, and a positive 5.14%.
PCI BIOTECH HOLD’s highest amplitude of average volatility was 12.14% (last week), 9.83% (last month), and 5.14% (last quarter).
More news about PCI BIOTECH HOLD (PCIB.OL).
